Tying Alcohol to Poor Sleep to Discourage Drinking
This transcript has been edited for clarity.
Welcome to Impact Factor , your weekly dose of commentary on a new medical study. I'm Dr F. Perry Wilson from the Yale School of Medicine.
You may not have realized it yet, but we are full-on in the era of biofeedback. I remember a few years ago when my smartwatch started reporting on my heart rate variability during sleep.
To be honest, I didn't even know what this metric really meant. But I did notice something fairly early on. On nights when I drank alcohol, my heart rate variability went down.
Human brains are really good at linking pieces of data like that, and I kept an eye on it, with additional nights of drinking or not drinking and more reports of heart rate variability only strengthening the association. This is not unique to me, of course — multiple studies have demonstrated the link between alcohol and decreased parasympathetic tone, which is the thing that causes the decrease in heart rate variability.
But for me, it was the first time I really saw a physiologic consequence of alcohol intake right before my eyes. Sure, everyone has had a hangover, but this phenomenon was there even if I had only had a glass of wine and felt fine waking up.
And it had an effect on me. There was something about seeing that number — maybe it's my competitive nature — that made me want to improve it. I guess the behavioral scientists might call this gamification, but whatever you want to call it, the net-net was that I started drinking less.
This is the power of biofeedback: You get information about your physiologic state to make the effects of your actions more real. And, with wearable devices now ubiquitous, it seems like the perfect time to test whether anecdotes like mine hold up in the real world. We got a randomized trial to answer that question just last week.
I'm thinking about my wearable device this week because of this study, appearing in JAMA Network Open, examining the complex relationship between alcohol use and sleep in a population of 120 young adults aged 18-25. Full disclosure: This was a study out of Yale, but I was not involved in any way.
The researchers, led by Lisa Fucito, wanted to test whether biofeedback — in this case, making explicit the link between alcohol intake and sleep quality — could modify alcohol use behavior.
Let's digress for a minute to talk about alcohol and sleep. There is something of a two-way street here. In general, alcohol use decreases the quality of sleep; you wake up more, sleep less, and have less restful sleep overall. But bad sleep can also influence alcohol intake. After a poor night's sleep you have less self-control, less discernment — you might make worse decisions — and none of that is conducive to saying 'no thanks I've had enough' when someone is offering you a shot at the local watering hole.
To track alcohol intake and sleep quality, the researchers strapped two wearable devices on to each participant. The first was a sleep actigraphy monitor — basically a device that can tell how much you sleep, how deeply, the quality, and so on. The second device was an alcohol monitor. You may have heard of this 'SCRAM' technology that police sometimes use to ensure someone isn't drinking. It samples the alcohol we excrete in our sweat.
While every participant wore these devices for 2 weeks, only half of them were given the information the devices provided. The rest were divided into two control groups. One group was given some web-based information about the importance of sleep, and the other group received the same web-based information but were also asked to keep a diary of their drinking behavior and subjective sleep quality.
The intervention group is the interesting one here, of course. At the end of week 1 and 2, a trained coach reviewed each participant's data with them. They showed them their blood alcohol content, their sleep data, and crunched this all into clear numbers like the ones you see here.
This participant can see that on their non-drinking nights, their sleep quality is better than on their drinking nights.
So, with my personal anecdotal data as a guide, this intervention must clearly have led to decreased drinking, right? Well, sort of. But not really.
This is the number of drinks per week at each of four time points. Remember, the intervention only lasted for the first 2 weeks. The primary outcome was the number of drinks at week 12.
You can see quite clearly an interesting effect; all three groups drank less over time. The intervention with the cool biofeedback, the people who just kept a drinking diary, even the people who got the web-based sleep information program. Everyone.
This is actually a classic finding in studies like this known as the Hawthorne effect. It occurs when individuals change their behavior because they are aware they are being studied. You see it in all kinds of behavioral intervention studies. If they know you're watching, people are more likely to wash their hands, leave a tip, hold a door for a stranger. It's powerful. But it's also short lived. When the study is over, people tend to go back to their old behavior.
Unfortunately, this makes it tough to assess the intervention itself. Perhaps it really would work in the real world, when big brother isn't watching, but we can't tell in the world of a clinical trial because all the guinea pigs know they are guinea pigs.
That said, some of the secondary outcomes were positive. The intervention group had lower rates of sleep impairment and sleep disturbance. That's an odd finding since we know this improvement couldn't have been mediated by less alcohol drinking. Maybe feedback about your sleep quality makes you change other things independent of alcohol? Maybe you're just a bit more mindful about the whole thing?
We should also remember that these were all 18 to 25-year-olds. I don't want to sound like an old fogey here, but I will say that I think I was well into my 30s before I took a hard look at some of my less than healthy behaviors and started to make real changes. There are a lot of other pressures on these young adults. Cutting back on drinking may just not be the most important thing to them at this point in their life.
So, no, I'm not ready to give up on biofeedback as an agent of behavior change. I still think this area is promising, but we may need to come up with some more clever ways to study it. For now, I'm keeping an eye on my heart rate variability at night; I am a data guy after all. It may not work for everyone, but it works for me, and if it works for you, then that's good enough.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
13 hours ago
- Yahoo
Weight loss in your 40s and 50s can help slash your chronic disease risk, researchers say
Working to lose weight in your 40s and 50s may help to reduce your risk of developing a chronic disease, a new study reveals. Researchers based in the U.K. and Finland say they found health benefits in people who lost an average of 6.5 percent of their body weight in early middle age and maintained that weight loss throughout a period of 12 to 35 years. Those benefits especially include a lessened risk for cardiovascular disease and diabetes as well as an overall lower risk of death from chronic disease. 'The benefits of lifestyle-based weight management are widely discussed even though studies have found it surprisingly difficult to demonstrate health benefits beyond the prevention of diabetes,' University of Helsinki professor Dr. Timo Strandberg said in a statement. Strandberg was the lead author of the study which was published recently in the journal JAMA Network Open, the open-access journal of the American Medical Association. To reach these conclusions, the study tracked and analyzed the health of 23,000 white Europeans who were between the ages of 30 and 50 years old using data from three studies, conducted from 1985 to 1988, from 1964 to 1973, and between 2000 and 2013. They sorted the participants into four groups: people with persistent healthy weight, people who were overweight but became a healthy weight, people who were healthy and became overweight, and people who were overweight the entire time. 'Measurement of weight and height was conducted at a time when surgical and pharmacological weight-loss interventions were nearly nonexistent,' the authors noted. The cause of weight loss was not assessed, but given the age of the participants and lack of diagnosed disease, it was more likely intentional than caused by severe chronic conditions or frailty.' In one study, a reduction in body mass from overweight to normal weight over six years in mid-life was tied to a lower risk of developing chronic diseases. There was also a 48 percent lower risk for chronic illness compared to those who remained overweight, which largely held even after excluding participants who developed diabetes during follow-up. Another study showed a 57 percent risk for chronic illness. A third study, with the longest follow-up period, showed that weight loss in mid-life was associated with a 19 percent reduction in overall mortality. 'I'm certain that overall prevention of overweight and obesity starting in early life is absolutely the best thing to do,' Stranberg told The Independent. 'Our study indirectly proves this by showing that persistent healthy weight over the life-course is best.' He said that he hopes the findings will inspire people to see that lifestyle changes can lead to a longer life. 'This is particularly important today as more people are overweight than when the collection of our research data began 35 years ago,' he said in the statement.
Medscape
2 days ago
- Medscape
Even the ‘Nonverbal' Have a Voice
We became good friends through school growing up. One of us, Kayla, has cerebral palsy and is allegedly nonverbal (although she has so much to say). The other, Alexis, is an emergency medicine doctor at Yale. In a world in which people with disabilities are not granted full access, and sociocultural barriers make friendships like ours less common, we are grateful for the opportunity to understand each other's perspectives. Through our conversations about our experiences working in and seeking care from today's healthcare system, we have developed a unified and important ask: Please make sure that patients who might be considered 'nonverbal' due to cerebral palsy or other disabilities that affect communication — such as autism and aphasia — have a written communication plan documented in their electronic medical record. First, the communication plan should specify who needs to be involved in medical decision-making: whether the patient has an appointed guardian or can represent themselves. People often assume patients with a disability cannot make their own medical decisions. However, disabilities range in their symptoms, and many patients diagnosed as nonverbal can self-represent. Regarding cerebral palsy more specifically, studies demonstrate only 45% of those with the condition also have an intellectual disability. Intellectual disability itself has varying degrees of impact on a person's capacity to make decisions. While the policies regarding guardianship vary by state, approximately 30% of people with developmental disabilities who do not have a coexisting intellectual disability have an appointed guardian and the other 70% self-represent, according to the National Association of State Directors of Developmental Disabilities Services. Whether a patient has an appointed guardian depends on many factors, including the policies of their state, communication skills, family support, and the degree of intellectual disability. Communication plans should also provide guidance about other modes of communication beyond face-to-face interactions, such as phone calls and MyChart messaging. For example, Kayla finds it cumbersome that her vocalizations are sometimes required in phone calls even if it's simply to schedule a routine appointment: Heck, do they even know it's truly me if I'm just using an app to narrate my voice? From the physician perspective, Alexis knows it can be uncomfortable and challenging to figure out if a patient has a guardian and how to best communicate with the patient, especially during an emergency. She once took care of an adult with cerebral palsy whose mother insisted on speaking for him, as if he were still a child. Alexis mistakenly assumed his mother was his guardian (although she should have known better due to her friendship with Kayla). Noticing the dynamic, the patient grinned, then he flipped his mother and Alexis the bird. After Alexis apologized, he told her he always has this problem with doctors because he relies on his mother to drive him to appointments but resents how she tries to speak for him. A documented communication plan in the medical record would have prevented this injustice. In contrast, Kayla notes she does not have a guardian and represents herself, but her mother accompanies her to most of her appointments, and she trusts her mom to interpret without overstepping. Kayla believes it would be so much easier if their dynamic was clearly indicated in the medical record. A written communication plan should specify: Whether the patient can self-represent or has a guardian The patient's preferred communication methods, including any aids they use and where to find them. Aids may include augmentative and alternative communication devices, such as a tablet or picture board, as well as other approaches such as grimacing, yes/no questions, sign language, typing, and other strategies. For example, Kayla uses the iPad app Proloquo2Go and fingerspells. The written plan should also list other communication methods if the patient's preferred tools are unavailable Name and contacts of people who understand the patient's communication and can help guide staff if needed Sensory sensitivities that may impact communication. Some patients get distracted by bright lights or loud noises For patients with limited expressive communication, a list of patterns of behavior and nonverbal cues that might indicate their needs, such as grimacing when in pain or opening their mouth when hungry Here's our shared vision for a sample written communication plan: 'Patient has cerebral palsy. She makes her own medical decisions and self-represents. Her preferred methods of communication include using the Proloquo2Go app on her iPad, which is attached to her wheelchair or stored in her bag. If unavailable, she fingerspells. She vocalizes in short phrases when needed, but other methods allow her to more effectively communicate. In an emergency, please contact her mother [contact information]. Other people who fully understand her communication modes and with whom she feels comfortable speaking openly about her health include [names, contact information]. Please do not share any information with other people.' We agree that the relationships formed between patients and healthcare workers are among our most valuable resources. Having a written communication plan allows everyone involved in caring for patients considered nonverbal to provide the highest quality compassionate healthcare. We do not want to see precious time wasted on re-establishing ground rules for communication when this information should be readily available for everyone involved in their care, from doctors and nurses to medical assistants, pharmacists, social workers, and receptionists. Every patient deserves equitable care, and our time together is best spent addressing medical needs. While some electronic medical records allow comments about accessibility, these often end up buried somewhere in hyperspace, such as under a Media tab or some other equivalent of a virtual junk drawer. Instead, we hope to see a link to the patient's communication plan, as well as any other helpful accommodations, easily visible on the face sheet for any healthcare worker who opens the chart. We also recommend that patients with disabilities bring a copy of their communication plan in case a healthcare worker cannot access it. With a little intentionality, we all have the power to improve our communication with each other. Kayla Ireland is a co-author of the book , 'Living with Cerebral Palsy.' She also hosts the podcast 'Kindly Neurodivergent with Kay.' She advocates for the limitless potential within every individual.
Medscape
2 days ago
- Medscape
Oseltamivir Decreases Hospital Mortality Risk of Influenza
Treating patients with severe influenza with oseltamivir in the first 2 days after hospital admission was associated with a lower in-hospital mortality risk, earlier discharge, and lower readmission rate compared with supportive care, new data indicated. The additional evidence supports current guideline recommendations to treat all people hospitalized with influenza with an antiviral agent, regardless of how long they have been ill. The study, led by Anthony D. Bai, MD, assistant professor of infectious diseases at Queen's University in Kingston, Ontario, was published on June 10 in JAMA Network Open. Reduced Mortality Risk Each year, influenza causes 12,200 hospitalizations and 3500 deaths in Canada. It causes between 140,000 and 810,000 hospitalizations and 12,000 to 61,000 deaths in the United States. And despite guidelines in both countries that recommend treatment for all entering the hospital with influenza, clinical practice varies widely, Bai told Medscape Medical News . The researchers' study found that in Ontario, 30% of clinicians were not treating this population with oseltamivir. Researchers examined data from the General Medicine Inpatient Initiative database, which includes internal medicine and intensive care unit (ICU) patients admitted to participating hospitals in Ontario. Data included demographics, diagnoses, interventions, discharge, readmission, medication orders, and bloodwork results. The cohort study included 11,073 patients (average age, 72.6 years). Researchers found an adjusted risk reduction of 1.8% for in-hospital mortality when oseltamivir was given, compared with supportive care median length of stay was 4.4 days and 4.9 days in the oseltamivir and supportive care groups, respectively. After discharge, 645 patients (8.5%) in the oseltamivir group and 336 patients (9.8%) in the supportive care group were readmitted, with an adjusted risk difference of -1.5%. 'Some clinicians believe there won't be much benefit to treatment with oseltamivir,' said Bai, likely because of the dearth of evidence supporting the guidelines. 'There's been a lot of controversy about the benefit of oseltamivir in the outpatient population, where a recent meta-analysis showed it didn't really prevent hospitalizations. But there is a signal that it decreased in-hospital mortality. If a similar benefit is proven in a future randomized, controlled trial, it would add a lot of convincing evidence that there's a significant benefit to oseltamivir treatment.' The expanded version of the large RECOVERY randomized, controlled trial in the United Kingdom looks at that question, he noted. But until results are available, 'we should go by the current guideline recommendations.' Remaining Questions Wendy Sligl, MD, professor of critical care medicine and infectious diseases at the University of Alberta in Edmonton, told Medscape Medical News that the 1.8% in-hospital mortality reduction may seem small. 'Keep in mind, this is in all hospitalized patients, which includes a spectrum of disease severity from those not needing supplemental oxygen to those on a ventilator.' She pointed out that less than 10% of the patients in this study were admitted to the ICU. The number needed to treat is an important consideration with these results, she pointed out. 'Given this mortality reduction, you would need to treat approximately 55 patients to prevent one death. When the outcome is as devastating as death, and the drug is relatively safe and inexpensive, treatment seems reasonable, given even a small reduction in mortality.' Sligl also noted the need for high-quality evidence from randomized, controlled trials, including RECOVERY, in hospitalized patients with influenza. 'In addition, the most severe patients, those in the ICU with respiratory failure requiring high-flow oxygen or mechanical ventilation, should be specifically studied.' Beyond whether antiviral therapy is beneficial, she said, other questions remain, such as which antiviral is best and at what dose and duration. Other questions include whether an antiviral therapy should be used alone or in combination with another antiviral therapy and at what time in which patients. 'The best quality data we have for the treatment of influenza are in healthy outpatients, where treatment has been shown to reduce symptom severity and duration. Data for antiviral use in hospitalized patients with influenza are largely observational, suggesting a small mortality benefit with treatment,' Sligl explained. In the current study, she noted, 'target trial emulation with propensity scoring helped to minimize bias, which is a methodologic strength.' No funding source for this study was reported. Bai and Sligl reported having no relevant financial relationships.
